Special attention shall be given to substances which are carcinogenic, mutagenic or toxic to reproduction (‘CMR’), in accordance with Part 3 of Annex VI to Regulation (EC) No 1272/2008 of the European Parliament and of the Council [1], and to substances having endocrine disrupting properties for which there is scientific evidence of probable serious effects to human health and which are identified in accordance with the procedure set out in Article 59 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council [2].10.4.
Tabharfar aird ar leith ar shubstaintí atá carcanaigineach, só-ghineach nó tocsaineach don atáirgeadh (“CMR”), i gcomhréir le Cuid 3 d'Iarscríbhinn VI a ghabhann le Rialachán (CE) Uimh. 1272/2008 ó Pharlaimint na hEorpa agus ón gComhairle [1], agus ar shubstaintí ina bhfuil airíonna réabtha iontálach a bhfuil fianaise eolaíoch ina leith ann go bhfuil éifeachtaí tromchúiseacha acu ar shláinte an duine agus a shainaithnítear i gcomhréir leis an nós imeachta a leagtar amach in Airteagal 59 de Rialachán (CE) Uimh. 1907/2006 ó Pharlaimint na hEorpa agus ón gComhairle [2].10.4.